跳至主要内容
临床试验/NCT00250302
NCT00250302已完成1 期

Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
24
试验地点
1
主要终点
Safety

研究概览

简要总结

Mesenchymal stem cells are found in bone marrow, and have the ability to differentiate into different tissue types. The primary objective of the study is to examine the safety of using such cells to treat patients suffering from distal tibial shaft fractures. The cells will be isolated from the patient's bone marrow, loaded onto a carrier and implanted locally at the fracture site.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ages 18 and
  • males not involved in active military duty. females- non child bearing potential. distal tibia third fracture without joint involvement. fracture treated by IM nail, percutaneous plating or external fixation.

排除标准

  • active systemic or local infection. history of malignancy radiotherapy or chemotherapy. active autoimmune disease. any past or present immunosuppressive treatment. fracture treated by open reduction. fracture grade gustillo grade IIIB, IIC. use of steroids in past 6 months. chronic renal insufficiency. administration of marrow suppressive drugs. history of metabolic bone disease. administration of drugs that may interfere with bone metabolism.

结局指标

主要结局

Safety

Number of patients reaching clinical union of fracture

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验